Amanda represents clients in antitrust litigation and government antitrust investigations. She represents clients in various industries, including manufacturing, retail, steel, energy, transportation and entertainment in merger and non-merger investigations before the U.S. Department of Justice and the Federal Trade Commission. Amanda provides compliance training and counseling to businesses and organizations on joint ventures and competitor collaborations, price discrimination, distributor relations and other competition-related issues. Amanda also represents clients in class action and other complex litigation matters. Amanda draws on her significant experience as a Staff Attorney in the Bureau of Competition, Mergers III Division, of the U.S. Federal Trade Commission. During this time, she served as the lead attorney in negotiating consent decrees on behalf of the FTC and litigated numerous challenges to mergers and acquisitions in federal and administrative courts. In recognition of her accomplishments at the FTC, Amanda was awarded an Official Commendation for Meritorious Service. Amanda is admitted to practice before the U.S. Court of Appeals for the Federal Circuit and the U.S. District Court for the Western District of Wisconsin.
Working group to update pharmaceutical merger review in the US, Canada, UK and EuropeNorton Rose Fulbright, Robin Adelstein, Amanda Wait, Richard Wagner, Ian Giles, Jay Modrall and Marta Giner Asins, 31 March 2021